Previous close | 10.60 |
Open | 11.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 11.00 - 11.00 |
52-week range | 3.16 - 13.00 |
Volume | |
Avg. volume | 21 |
Market cap | 573.319M |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.25 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 62.88 |
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?